antibody

(Lauren Chapman/IPB News)

The Food and Drug Administration (FDA) has given emergency authorization to Eli Lilly for its COVID-19 antibody drug bamlanivimab.

(Lauren Chapman/IPB News)

Eli Lilly and Company has begun what it calls the first study in the world for a potential COVID-19 antibody treatment for humans.

In phase one of the study, hospitalized COVID-19 patients are being dosed at medical facilities to closely track safety and response to the treatment, with initial results expected in about one month.